IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 995 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (251 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References

 Article Access Statistics
    Viewed1042    
    Printed15    
    Emailed0    
    PDF Downloaded184    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2016  |  Volume : 48  |  Issue : 2  |  Page : 223
 

Postgraduate (clinical) pharmacology curriculum: A balancing act


Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India

Date of Web Publication17-Mar-2016

Correspondence Address:
Ashwin Kamath
Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.178843

Rights and Permissions



How to cite this article:
Kamath A. Postgraduate (clinical) pharmacology curriculum: A balancing act. Indian J Pharmacol 2016;48:223

How to cite this URL:
Kamath A. Postgraduate (clinical) pharmacology curriculum: A balancing act. Indian J Pharmacol [serial online] 2016 [cited 2019 Nov 14];48:223. Available from: http://www.ijp-online.com/text.asp?2016/48/2/223/178843


Sir,

The proposed draft pharmacology curriculum for medical postgraduates in India is indeed a welcome move which was long overdue.[1] The changes seem to be largely driven by the need to improve medical education, accommodate the ethical concerns regarding animal experimentation, and the practical need to equip the new pharmacologists with knowledge relevant to their future careers. In particular, the emphasis on inclusion of more of clinical aspects (clinical postings, case-based learning, interdepartmental symposia, patient-centric teaching, etc.) is a significant step forward. While some of these are already being practiced in some institutions, the draft proposal serves to provide a roadmap ensuring uniformity and importantly, incorporate these as a part of student assessment. The difficulty in designing a well-structured curriculum in clinical pharmacology is partly explained by the following statement by JW Black – ”Gradually the traditional departments, which have organized biomedical research and teaching for most of this century, are disappearing into larger, anonymous biological condominiums. Pharmacology departments have been a prominent casualty. Pharmacology, and particularly clinical pharmacology, seems to me to be in the throes of an identity crisis.”[2] Indeed this dilution of borders is the source of a basic question asked by many nonpharmacologists, and young pharmacologists-What do pharmacologists do? In reply to the question “What is pharmacology?” Sir John Gaddum famously replied, “Pharmacology is what pharmacologists do.”[3] Interestingly, JK Aronson, President Emeritus of the British Pharmacological Society, conducted a survey in 2012 on “What do clinical pharmacologists do?” in the United Kingdom.[4] To be clear, those with a MD Pharmacology degree are clinical pharmacologists and hence, a pharmacology curriculum (particularly the currently practiced pharmacology practicals) largely divorced from the “clinical” aspect would hardly justify the degree. Aronson's survey revealed five broad responsibilities for a clinical pharmacologist– teaching, research, clinical work, policy and administration, editorial work and writing with 70% of the time being spent on research and clinical work.[4],[5] Assuming that the same would be broadly applicable to clinical pharmacologists in India, a balanced approach is necessary to train the pharmacologist in each of these responsibilities. Relating this to the current draft postgraduate curriculum, one does find each of the five aspects being addressed. The challenge now is to design and develop the individual components for each learning domain in a way that ensures reasonable uniformity and is subjected to proper assessment methods.

Financial Support and Sponsorship

Nil.

Conflicts of Interest

There are no conflicts of interest.





 
  References Top

1.
Badyal DK, Desai C, Tripathi SK, Dhaneria SP, Chandy SJ, Bezbaruah BK. Postgraduate pharmacology curriculum in medical institutions in India: Time for need-based appraisal and modifications. Indian J Pharmacol 2014;46:584-9.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.
Black JW. TiPS on identity. Trends Pharmacol Sci 1996;17:121.  Back to cited text no. 2
    
3.
Laurence D. What is pharmacology? A discussion. Trends Pharmacol Sci 1997;18:153-5.  Back to cited text no. 3
    
4.
Aronson JK. What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists. Br J Clin Pharmacol 2012;73:161-9.  Back to cited text no. 4
    
5.
Aronson JK. A manifesto for clinical pharmacology from principles to practice. Br J Clin Pharmacol 2010;70:3-13.  Back to cited text no. 5
    




 

Top
Print this article  Email this article
 

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow